Qianxue Chen and colleagues, through transcriptomic sequencing, in vivo and in vitro experiments, found that the SREBP‐specific inhibitor fatostatin induces ferroptosis in glioblastoma by inhibiting the AKT/mTORC1/GPX4 signaling pathway [106]. This evidence concerns the gene AKT1 and glioblastoma.